Clinical Decision Making in Multiple Myeloma: CAR-T in the 2nd Line Treatment Setting

Medical experts examine the factors that make Sarah an ideal candidate for CAR-T therapy in the second-line setting, focusing on how her age, fitness, and early relapse influence treatment decisions and exploring alternative options.

EP: 1.Meet Sarah, a 55-year-old Businesswoman With Multiple Myeloma Considering CAR-T Therapy With Ide-cel

Now Viewing

EP: 2.Clinical Decision Making in Multiple Myeloma: CAR-T in the 2nd Line Treatment Setting

Video content above is prompted by the following:

• What factors make Sarah an ideal candidate for CAR-T therapy in the second-line setting?
  • How does her age, fitness, and early relapse influence your decision?
  • What other treatment options would you consider for this patient?

Recent Videos